Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism-Reference-Cited by-同舟云学术

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism

Published:2012-11-28 Issue:18 Volume:26 Page:2275-2284
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Marcelino José M.,Borrego Pedro,Nilsson Charlotta,Família Carlos,Barroso Helena,Maltez Fernando,Doroana Manuela,Antunes Francisco,Quintas Alexandre,Taveira Nuno

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference60 articles.

1. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection.;Berry;J Hum Virol,1998

2. Increased frequency of circulating CCR5 CD4 T cells in human immunodeficiency virus type 2 infection.;Soares;J Virol,2006

3. Reduced rate of disease development after HIV-2 infection as compared to HIV-1.;Marlink;Science,1994

4. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.;Drylewicz;AIDS,2008

5. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity.;Cavaleiro;AIDS,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study;eBioMedicine;2023-12

2. An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates;International Journal of Molecular Sciences;2023-05-22

3. Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting;2023-01-22

4. Tracking Coreceptor Switch of the Transmitted/Founder HIV-1 Identifies Co-Evolution of HIV-1 Antigenicity, Coreceptor Usage and CD4 Subset Targeting: The RV217 Acute Infection Cohort Study;2023

5. Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals;Microbiology Spectrum;2022-12-21